Faception Revenue and Competitors
Estimated Revenue & Valuation
- Faception's estimated annual revenue is currently $362.5k per year.
- Faception's estimated revenue per employee is $72,500
Employee Data
- Faception has 5 Employees.
- Faception grew their employee count by -17% last year.
Faception's People
Name | Title | Email/Phone |
---|
Faception Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $212.3M | 728 | -15% | N/A | N/A |
#2 | $94.4M | 521 | -27% | N/A | N/A |
#3 | $34.1M | 214 | 9% | N/A | N/A |
#4 | $77M | 425 | -3% | N/A | N/A |
#5 | $126.5M | 698 | -6% | N/A | N/A |
#6 | $17.7M | 122 | -35% | $52.7M | N/A |
#7 | $26.7M | 171 | -4% | $89.4M | N/A |
#8 | $89.5M | 494 | -23% | N/A | N/A |
#9 | $62.5M | 345 | 1% | N/A | N/A |
#10 | $15.7M | 108 | -38% | $115M | N/A |
What Is Faception?
Faception an Israeli startup, developed and markets a Facial Personality Analytics Technology. Our breakthrough computer-vision and AI technology reveals personalities and threats from people’ face images in real-time. Dedicated to the HLS, Public Safety and Smart Cities, our real-time intelligence solutions detects Anonymous Offenders/Terrorists, by revolutionary Predictive Screening AI technology, to perform Preventive Actions to save life and keep public safety. Replying to the COVID-19 age, our solutions enable sorting and rating risks inherent in anonymous people. The set of algorithms developed will be adapted to early detection of visual symptoms characteristic of COVID-19 and other pandemic patients, as a new Public Health Safety service tool. We are already approved to begin human trials on late July 20.
keywords:N/AN/A
Total Funding
5
Number of Employees
$362.5k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | -71% | N/A |
#2 | $0.4M | 6 | -40% | N/A |
#3 | $0.6M | 6 | -25% | N/A |
#4 | $0.9M | 7 | -22% | N/A |
#5 | $1.1M | 7 | -30% | N/A |